Petros V. Anagnostopoulos, MD, MBA, FACS
- Surgeon in Chief, American Family Children’s Hospital
- Chief, Section of Pediatric Cardiothoracic Surgery
- Division of Cardiothoracic Surgery
600 Highland Ave.
Madison, WI 53792-0001
- MD, University of Athens Medical School, Athens Greece, 1994
- Residency in General Surgery, Henry Ford Hospital, Detroit, MI, 1997
- Postdoctoral Fellowship, Heart and Vascular Institute of Henry Ford Hospital, Detroit, MI, 2002
- Residency in Cardiothoracic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, 2004
- Fellowship in Pediatric Cardiac Surgery, University of California San Francisco School of Medicine, San Francisco, CA, 2006
Dr. Anagnostopoulos specializes in complex neonatal and infant cardiac reconstructive surgery, pediatric heart surgery, adult congenital cardiac surgery, single ventricle palliation, extracorporeal life support, extracorporeal membrane oxygenation, ventricular assist devices, minimally invasive cardiac surgery, hybrid surgical-catheterization cardiac surgery, off-pump cardiac surgery, complex mitral and tricuspid valve repair, aortic root surgery, tetralogy of Fallot, coronary artery anomalies, Ross operations, obstructive cardiomyopathy, and heart transplantation.
Dr. Anagnostopoulos provides a wide range of services including Neonatal and Infant Cardiac Reconstructive Surgery, Pediatric Heart Surgery, Adult Congenital Cardiac Surgery, Single Ventricle Palliation, Extracorporeal Life Support, Ventricular Assist Devices, Minimally Invasive Cardiac Surgery, Hybrid Surgical-Catheterization Cardiac Surgery, Off-Pump Cardiac Surgery, Complex Mitral and Tricuspid Valve Repair, Aortic Root Surgery, Tetralogy of Fallot, Coronary Artery Anomalies, Ross Operations, Obstructive Cardiomyopathy, Heart Transplant.
Dr. Anagnostopoulos’s research interests include coagulopathy associated with supraceliac aortic clamping and development of rapid deployment extracorporeal life support program.
Systems of Care Factors Should Be Considered in Regionalization of Congenital Cardiac Surgery.
Anagnostopoulos PV, Cartmill RS, Yang Q, Schumacher JR, Fernandes-Taylor S, Hermsen JL, DeCamp MM
Ann Thorac Surg 2022 Nov 12;
[PubMed ID: 36379268]
Commentary: Regionalization of congenital heart surgery. If you don't know where you are going, you'll end up someplace else.
Alsoufi B, Anagnostopoulos PV
J Thorac Cardiovasc Surg 2023 Apr; 165(4): 1551-1553
[PubMed ID: 35811141]
Nicardipine Is a Safe, Efficacious, and Cost-Effective Antihypertensive for Neonates and Young Infants Undergoing Cardiac Surgery.
Lushaj E, Hermsen JL, Nelson K, Amond K, Bogenschutz M, Arndt S, Wilhelm M, Anagnostopoulos PV
World J Pediatr Congenit Heart Surg 2022 May; 13(3): 341-345
[PubMed ID: 35446217]
Commentary: Obstruction or No Obstruction? That Is the Question. Is CT the Answer We've Been Searching for?
Allen CC, Anagnostopoulos PV
Semin Thorac Cardiovasc Surg 2023; 35(1): 138-139
[PubMed ID: 35331897]
Is Porcine Small Intestinal Submucosal Extracellular Matrix (ECM) a Suitable Material for Right Ventricular Outflow Tract Reconstruction in Association With Pulmonary Valve Replacement?
Burke CR, Lewis E, Schreiter NA, Bartlett H, Krieger EV, Anagnostopoulos PV, Verrier ED, Hermsen JL
World J Pediatr Congenit Heart Surg 2022 Jul; 13(4): 518-521
[PubMed ID: 34985359]